The RNAs of hepatitis C virus (HCV) isolates from 62 patients with chronic HCV infection were analyzed by direct sequencing of the 5' untranslated region. Two important sequence motifs were recognized: one between positions -170 and -155 and the other between positions -132 and -117. These motifs are partly complementary. All three previously published genotypes were observed; 34 (55%) isolates Since the discovery of hepatitis C virus (HCV), a flavi-like virus with a positive-sense, single-stranded RNA genome of approximately 9,400 nucleotides (6), several full-length sequences have been obtained from various isolates (7, 14, 21, 22, 26) and investigators have proposed (3, 4, 9, 12, 18, 21) that HCV isolates be classified into different types or subtypes. On the basis of all available sequence information, Chan et al. (4) distinguished three HCV genotypes. Type 1 isolates include the prototype strain HCV-1 (7) and strains HCV-H (19), HCV-K1 (9), HCV-J (14), and HCV-BK (26); type 2 includes strains HCV-K2 (9), HC-J6 (22), and HC-J8 (21); type 3 includes strains HCV E-bl (4), HCV-T (18), and HCV1196 (17).
Since the discovery of hepatitis C virus (HCV), a flavi-like virus with a positive-sense, single-stranded RNA genome of approximately 9,400 nucleotides (6), several full-length sequences have been obtained from various isolates (7, 14, 21, 22, 26) and investigators have proposed (3, 4, 9, 12, 18, 21) that HCV isolates be classified into different types or subtypes. On the basis of all available sequence information, Chan et al. (4) distinguished three HCV genotypes. Type 1 isolates include the prototype strain HCV-1 (7) and strains HCV-H (19), HCV-K1 (9), HCV-J (14) , and HCV-BK (26); type 2 includes strains HCV-K2 (9), HC-J6 (22) , and HC-J8 (21) ; type 3 includes strains HCV E-bl (4), HCV-T (18) , and HCV1196 (17) .
HCV genotyping is of interest in viral transmission studies and HCV epidemiology. Furthermore, the success of interferon treatment (25, 28) may be type or subtype related.
There are several reasons to choose the 5' untranslated region (5' UTR) for genotyping. (i) Analysis of a large number of HCV isolates results in similar phylogenetic trees for the 5' UTR, the core, NS-3, and NS-5 regions (4); (ii) the observed mutation rate of the 5' UTR is extremely low (19, 20) ; (iii) sequence variation within the conserved 5' UTR is mainly limited to specific regions; and (iv) the putative secondary structure of the 5' UTR, as established from biochemical and phylogenetic data (1) , suggests functional conservation of this region.
In the study described here, the RNAs of 62 HCV isolates from patients in The Netherlands with chronic HCV infections were investigated to determine whether HCV genotyping by sequence analysis of PCR products derived from the 5' UTR could be performed.
MATERIALS AND METHODS
Patients. Sixty-two patients from The Netherlands between the ages of 26 and 74 years with elevated alanine aminotransferase levels, a biopsy-proven chronic non-A, non-B hepatitis, antibodies to HCV, and no recent history of infection with hepatitis B virus, hepatitis A virus, cytomegalovirus, or Epstein-Barr virus were analyzed.
Anti-HCV. Antibodies to HCV were tested by a secondgeneration enzyme immunoassay (Abbott, North Chicago, Ill.) and were confirmed by the recombinant immunoblot assay (RIBA-4; Ortho Diagnostics, Raritan, N.J.) according to the instructions of the manufacturer.
Blood plasma. For HCV RNA detection, EDTA-blood was collected by venipuncture, and plasma was prepared within 2 h after sampling. One-milliliter aliquots were quickly frozen in liquid nitrogen and were stored at -70°C until use.
HCV RNA PCR. HCV RNA was isolated from 100 ,ul of plasma by a modified version of the guanidinium method described previously (5 Nucleotide sequence accession number. The nucleotide sequences reported here have been deposited in the EMBL data library (accession numbers X58937 to X58953).
RESULTS
Sixty-two patients with chronic HCV infection were anti-HCV positive by enzyme immunoassay which was confirmed by RIBA-4, and were HCV RNA positive by reverse transcription-PCR aimed at the 5' UTR. The sense primer HCV18, which was based on the first published HCV sequences (10, 23), was initially used for the diagnosis of HCV viremia by PCR. In the case of low yields of PCR products, the sense primer HCV35 improved the PCR results considerably (data not shown), and in these cases, PCR products obtained by HCV35 were used for sequence analysis.
Nested PCR products were sequenced directly, and the results are presented in Fig. 1 Comparison between the sequences obtained in the present study (nt -262 to -66) and all previously reported 5' UTR sequences (2-4, 11) revealed a number of new 5' UTR mutations within all genotypes (Fig. 1) .
The overall sequence heterogeneity among the four genotypes in the present study ranged from 4% between types 1 and 4 to 11% between types 2 and 3, whereas heterogeneity within each type was less than 2.5% (Table 1) . Mutations were not randomly distributed along the 5' UTR but were clustered in motifs 1 and 2. Comparison of these motifs among the four genotypes revealed strong conservation within each genotype and showed significant differences between the genotypes (Table 1 ). Further analysis of the sequence variation in motifs 1 and 2 revealed the presence of covariants, i.e., compensatory mutations in each motif, maintaining the postulated secondary structure of the 5' UTR genomic RNA (1). The P values for the occurrence of one, two, or three covariant mutations in motifs 1 and 2 to have arisen by chance were very low (P = 0.06, P = 0.004, and P = 0.0002, respectively). Covariance occurred at positions -164, -163, -161, and -155 in motif 1 and positions -132, -124, -122, and -121 in motif 2. This covariance was consistently observed in the sequences of all 62 isolates, indicating the importance of this phenomenon.
DISCUSSION
Sequence analysis of the 5' UTR of HCV isolates from 62 patients with chronic HCV infection allowed consistent and efficient genotyping. Fifty-eight (94%) isolates could be classified into the three different genotypes proposed by Chan et al. (4) . Identification of the genotypes is essentially based on the sequence variation in the defined motifs 1 and 2.
All three genotypes reported so far were observed in the HCV-infected patient population in The Netherlands. The coexistence of HCV genotypes in several geographic regions has been indicated earlier (3, 4) . However, little is known about the distribution of HCV genotypes in Europe. The majority of published isolates belong to type 1 (8, 16 [4] ) and genotype 4. Previously published sequences are identified by their original names: HCV-1 (7); DK7, SA10, US10, SA1, and DK13 (2); HCV-BK (26); HC-J6 (22) ; EB-12 and EB-7 (4); and HCV1196 (17) . Numbers (1)
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frequency of double infections which has been observed by others (24, 28) by using type-specific primers or probes.
New 5' UTR sequences were observed in 21 of the 62 isolates analyzed. The distribution of the sequence variation was not random. Recently, the putative secondary structure and possible functional elements of the 5' UTR of the HCV genome were postulated (1, 27, 29) . The -136 and -151. Most of the point mutations are located outside of the defined sequence motifs and do not affect classification. Only two isolates showed single point mutations within the two motifs: HC2-N2 contained a G at position -127, and HC3-N2 contained a C at position -118. Despite these variations, classification of HC2-N2 and HC3-N2 as types 2 and 3, respectively, was obvious.
The overall sequence variation between the 197-bp 5' UTR fragments was not statistically significant, because only 6 to 21 mutations were observed among the four genotypes. Because the mutations were not randomly distributed along the 5' UTR, it is impossible to apply regular statistical methods to this problem, because these require a random distribution of events. The secondary structure, i.e., the stem-loop structure formed by the partial complementarity of motifs 1 and 2, must be maintained (with a sufficiently low free energy) to function properly as an internal ribosomal entry site (27) . Therefore, mutations in these motifs have functional restrictions. Comparison of the 5' UTR sequences described in this report reveals the existence of covariants. These complementary mutations in motifs 1 and 2 indeed completely conserve the secondary structure, indicating the significance of covariance. On the basis of these findings, classification of HCV isolates should preferably be based on covariance in motifs 1 and 2.
In conclusion, consistent genotyping based on 5' UTR sequence analysis is possible and may complement studies on antiviral treatment and the transmission of HCV.
